Why PhRMA wants the EU on the USTR’s IP watch list
Pharmaceutical industry organisation PhRMA has asked the US government to put the EU on the USTR’s Special 301 Report, which identifies countries the US views as the worst offenders when it comes to IP, in a move that has left PhRMA's critics extremely concerned
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: